Moderna Stock Crash Intensifies: Losses Top $130 Billion After Scientists Find Covid Boosters Aren’t Halting Omicron Infections
- Saturday, January 22, 2022, 7:13
- Market
- Add a comment
Moderna was last year’s third-best-performing stock in the S&P—it’s now this year’s worst.
About the Author
admin123 has written 23446 stories on this site.
